Back in October, The NY Times reported that President Obama had lifted restrictions that allowed researchers to use only low-THC strains of cannabis approved by the Drug Enforcement Administration (DEA) to conduct their research. Just producing this type of strain and obtaining proper approval from authorities took years to acquire, creating distress and anger amongst […]

by

Editor’s Note: This week Leafly publishes “Cannabis Jobs Count,” a special series on jobs in the legal cannabis economy. The federal government refuses to acknowledge the existence of more than 120,000 full time jobs in the legal cannabis field. So we thought we’d ask Leafly contributor Rob Reuteman to introduce five real people in five […]

by

AXIM Biotechnologies (AXIM Biotech) cannabinoid research and development says it has received positive pharmacokinetic (PK) data results on its CanChew Plus CBD Gum. As a result, the company said it will start clinical trials on the gum for alleviating the symptoms of irritable bowel syndrome (IBS).  IBS patient trial Volunteers took part in a study […]

by

BOSTON, MA–(Marketwired – Jan 6, 2017) – Cannabis Science, Inc. ( OTC PINK : CBIS ), a U.S. company specializing in the development of cannabinoid-based medications, is proud to announce a collaborative research agreement with Dana Farber/Harvard Cancer Center (DF/HCC). The agreement lays the foundation for a cooperative research initiative to explore and develop new […]

by

You’ve heard about the benefits of smoking cannabis — or eating edibles — but what about consuming the plant in its raw form? It turns out some health professionals believe consuming raw cannabis has its own set of benefits. “While the exact nutritional profile of cannabis has yet to be determined, it seems safe to […]

by

BOSTON, MA–(Marketwired – Jan 6, 2017) – Cannabis Science, Inc. ( OTC PINK : CBIS ), a U.S. company specializing in the development of cannabinoid-based medications, is proud to announce a collaborative research agreement with Dana Farber/Harvard Cancer Center (DF/HCC). The agreement lays the foundation for a cooperative research initiative to explore and develop new […]

by

BOSTON, MA–(Marketwired – Jan 6, 2017) – Cannabis Science, Inc. ( OTC PINK : CBIS ), a U.S. company specializing in the development of cannabinoid-based medications, is proud to announce a collaborative research agreement with Dana Farber/Harvard Cancer Center (DF/HCC). The agreement lays the foundation for a cooperative research initiative to explore and develop new […]

by

BOSTON, MA–(Marketwired – Jan 6, 2017) – Cannabis Science, Inc. ( OTC PINK : CBIS ), a U.S. company specializing in the development of cannabinoid-based medications, is proud to announce a collaborative research agreement with Dana Farber/Harvard Cancer Center (DF/HCC). The agreement lays the foundation for a cooperative research initiative to explore and develop new […]

by

BOSTON, MA–(Marketwired – Jan 6, 2017) – Cannabis Science, Inc. ( OTC PINK : CBIS ), a U.S. company specializing in the development of cannabinoid-based medications, is proud to announce a collaborative research agreement with Dana Farber/Harvard Cancer Center (DF/HCC). The agreement lays the foundation for a cooperative research initiative to explore and develop new […]

by

CATEGORIES: International Cannabis NewsMarijuana CultureMedical Marijuana News Share Tweet The Australian woman raided by law enforcement for manufacturing medicinal cannabis oil, which she provided for free to terminally ill patients, said she has tried to meet with Health Department officials for more than two years prior to the crackdown at her home, according to an […]

by